Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision v3.6.0 is added and the previous v3.5.5 revision is removed. The page now includes a notice that the study is no longer looking for participants, indicating recruitment has closed.SummaryDifference0.3%

- Check15 days agoChange DetectedA new revision entry, v3.5.5, was added and the previous entry, v3.5.4, was removed. This reflects a minor update to the page's revision history.SummaryDifference0.1%

- Check37 days agoChange DetectedThe record history now shows a new revision entry, updating from v3.5.3 to v3.5.4. This reflects an incremental update to the page's revision metadata and change tracking.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s interface/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/site software revision rather than a change to the ClinicalTrials.gov record history.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded revision: v3.5.2 to the history. Removed revision: v3.5.0 from the history.SummaryDifference0.1%

- Check95 days agoChange DetectedA new revision entry, v3.5.0, has been added to the history. The older entry, v3.4.3, has been removed.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.